Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$70.17
-4.67%
Mkt Cap $10.35B
Analyst Ratings
Buy
16
Hold
5
Sell
0
Price Target (26 analysts)
$78.78
Range $35.00 – $110.00
Implied Upside
+12.3%
Consensus $78.78 vs current $70.17